LGIH vs RARE · P/E 7.0, rev $848.9M vs rev $350.0M
LGI Homes (LGIH) versus Ultragenyx (RARE) — a side-by-side from cached financials, not a winner call.
LGI Homes (LGIH) is a residential construction company listed on US.
Ultragenyx (RARE) is a biotechnology company listed on US.
Latest reported LGIH revenue for 2026-06-30 was $848.9M. Net income was $29.1M. LGIH currently screens at market cap $1.27B and trailing P/E 7.0.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
LGIH currently screens at market cap $1.27B and trailing P/E 7.0. RARE currently screens at market cap $2.79B.
Not investment advice. Open the LGIH and RARE stock pages for the full models.
Not investment advice.